MedTrace Logo

Endophthalmitis After Intravitreous Anti-VEGF Injections in Patients Receiving vs. Not Receiving Topical Antibiotics

NCT02810587 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2016-06-23

No results posted yet for this study

Summary

This is a prospective case series which aims to determine the incidence of endophthalmitis following intravitreous anti-vascular endothelial growth factor (VEGF) injection comparing between eyes receiving post-injection antibiotics drops and those not receiving antibiotics drops treated at Chiang Mai University Hospital between May 2015 and April 2017 (2-year period).

Conditions

  • Endophthalmitis

Interventions

DRUG

Topical antibiotics following injection

Either receive or not receive topical antibiotics following intravitreous injection

Sponsors & Collaborators

  • Chiang Mai University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02810587 on ClinicalTrials.gov